Xenobiotic metabolism and disposition in human lung: Transcript profiling in non-tumoral and tumoral tissues

Biochimie

Volumn 93, Issue 6, 2011, Pages 1012-1027

  Leclerc, Julie ^a   Courcot Ngoubo Ngangue, Elisabeth ^a   Cauffiez, Christelle ^a   Allorge, Delphine ^a   Pottier, Nicolas ^a   Lafitte, Jean Jacques ^b   Debaert, Michel ^c   Jaillard, Sophie ^d   Broly, Franck ^a   Lo Guidice, Jean Marc ^a  

^a UFR3S Pharmacie   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c Clinique de la Louvire   (France)

^d Polyclinique du Bois   (France)

Author keywords

Lung; Nuclear receptors; TaqMan Low Density Arrays (TLDA); Transporters; Xenobiotic metabolizing enzymes (XME)

Indexed keywords

CELL NUCLEUS RECEPTOR; CYTOCHROME P450 2A; CYTOCHROME P450 4B1; GLUTATHIONE TRANSFERASE P1; MESSENGER RNA; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; XENOBIOTIC METABOLISM;

EID: 79955059066     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2011.02.012     Document Type: Article

References (68)

1. K. Nakata, Y. Tanaka, T. Nakano, T. Adachi, H. Tanaka, T. Kaminuma, and T. Ishikawa Nuclear receptor-mediated transcriptional regulation in phase I, II, and III xenobiotic metabolizing systems Drug Metab. Pharmacokinet. 21 2006 437 457
2. J.V. Castell, M.T. Donato, and M.J. Gomez-Lechon Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach Exp. Toxicol. Pathol. 57 Suppl. 1 2005 189 204 (Pubitemid 40884492)
3. T. Langmann, R. Mauerer, A. Zahn, C. Moehle, M. Probst, W. Stremmel, and G. Schmitz Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues Clin. Chem. 49 2003 230 238 (Pubitemid 36143443)
4. M. Nishimura, H. Yaguti, H. Yoshitsugu, S. Naito, and T. Satoh Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR Yakugaku Zasshi 123 2003 369 375 (Pubitemid 41327466)
5. M. Nishimura, and S. Naito Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies Drug Metab. Pharmacokinet. 20 2005 452 477
6. K. Bleasby, J.C. Castle, C.J. Roberts, C. Cheng, W.J. Bailey, J.F. Sina, A.V. Kulkarni, M.J. Hafey, R. Evers, J.M. Johnson, R.G. Ulrich, and J.G. Slatter Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition Xenobiotica 36 2006 963 988 (Pubitemid 44844110)
7. J. Zhang, and J.R. Cashman Quantitative analysis of FMO gene mRNA levels in human tissues Drug Metab. Dispos. 34 2006 19 26 (Pubitemid 43042642)
8. M. Michael, and M.M. Doherty Tumoral drug metabolism: overview and its implications for cancer therapy J. Clin. Oncol. 23 2005 205 229 (Pubitemid 41702640)
9. S. Saviozzi, F. Cordero, M. Lo Iacono, S. Novello, G.V. Scagliotti, and R.A. Calogero Selection of suitable reference genes for accurate normalization of gene expression profile studies in non-small cell lung cancer BMC Cancer 6 2006 200
10. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 2001 402 408 (Pubitemid 34164012)
11. J. Leclerc, G. Tournel, E. Courcot-Ngoubo Ngangue, N. Pottier, J.J. Lafitte, S. Jaillard, E. Mensier, M. Lhermitte, F. Broly, and J.M. Lo-Guidice Profiling gene expression of whole cytochrome P450 superfamily in human bronchial and peripheral lung tissues: differential expression in non-small cell lung cancers Biochimie 92 2010 292 306
12. E. Hodgson, and R.L. Rose The importance of cytochrome P450 2B6 in the human metabolism of environmental chemicals Pharmacol. Ther. 113 2007 420 428 (Pubitemid 46149054)
13. T. Shimada Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons Drug Metab. Pharmacokinet. 21 2006 257 276
14. G. Tournel, C. Cauffiez, I. Billaut-Laden, D. Allorge, D. Chevalier, F. Bonnifet, E. Mensier, J.J. Lafitte, M. Lhermitte, F. Broly, and J.M. Lo-Guidice Molecular analysis of the CYP2F1 gene: identification of a frequent non-functional allelic variant Mutat. Res. 617 2007 79 89 (Pubitemid 46386086)
15. J.M. Lo-Guidice, D. Allorge, C. Cauffiez, D. Chevalier, J.J. Lafitte, M. Lhermitte, and F. Broly Genetic polymorphism of the human cytochrome P450 CYP4B1: evidence for a non-functional allelic variant Pharmacogenetics 12 2002 367 374 (Pubitemid 34816416)
16. S.A. Marchitti, C. Brocker, D. Stagos, and V. Vasiliou Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily Expert Opin. Drug Metab. Toxicol. 4 2008 697 720 (Pubitemid 352003194)
17. O.A. Barski, S.M. Tipparaju, and A. Bhatnagar The aldo-keto reductase superfamily and its role in drug metabolism and detoxification Drug Metab. Rev. 40 2008 553 624
18. D. Ross, J.K. Kepa, S.L. Winski, H.D. Beall, A. Anwar, and D. Siegel NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms Chem. Biol. Interact 129 2000 77 97 (Pubitemid 32061055)
19. J.D. Hayes, J.U. Flanagan, and I.R. Jowsey Glutathione transferases Annu. Rev. Pharmacol. Toxicol. 45 2005 51 88 (Pubitemid 40261798)
20. S. Anttila, A. Hirvonen, H. Vainio, K. Husgafvel-Pursiainen, J.D. Hayes, and B. Ketterer Immunohistochemical localization of glutathione S-transferases in human lung Cancer Res. 53 1993 5643 5648 (Pubitemid 23360265)
21. N. Nagahara, T. Ito, and M. Minami Mercaptopyruvate sulfurtransferase as a defense against cyanide toxication: molecular properties and mode of detoxification Histol. Histopathol. 14 1999 1277 1286 (Pubitemid 29447468)
22. M. Widerak, C. Ghoneim, M.F. Dumontier, M. Quesne, M.T. Corvol, and J.F. Savouret The aryl hydrocarbon receptor activates the retinoic acid receptoralpha through SMRT antagonism Biochimie 88 2006 387 397
23. C. Kohle, and K.W. Bock Coordinate regulation of phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2 Biochem. Pharmacol. 73 2007 1853 1862 (Pubitemid 46677898)
24. M.A. Satre, M. Zgombic-Knight, and G. Duester The complete structure of human class IV alcohol dehydrogenase (retinol dehydrogenase) determined from the ADH7 gene J. Biol. Chem. 269 1994 15606 15612 (Pubitemid 24202150)
25. C.M. Soref, Y.P. Di, L. Hayden, Y.H. Zhao, M.A. Satre, and R. Wu Characterization of a novel airway epithelial cell-specific short chain alcohol dehydrogenase/reductase gene whose expression is up-regulated by retinoids and is involved in the metabolism of retinol J. Biol. Chem. 276 2001 24194 24202
26. M. van der Deen, E.G. de Vries, W. Timens, R.J. Scheper, H. Timmer-Bosscha, and D.S. Postma ATP-binding cassette (ABC) transporters in normal and pathological lung Respir. Res. 6 2005 59
27. W. Ni, J.M. Thompson, C.A. Northcott, K. Lookingland, and S.W. Watts The serotonin transporter is present and functional in peripheral arterial smooth muscle J. Cardiovasc. Pharmacol. 43 2004 770 781 (Pubitemid 38679598)
28. S. Jalkanen, and M. Salmi A novel endothelial cell molecule mediating lymphocyte binding in humans Behring Inst. Mitt. 1993 36 43
29. S.Y. Chen, J.R. Lin, R. Darbha, P. Lin, T.Y. Liu, and Y.M. Chen Glycine N-methyltransferase tumor susceptibility gene in the benzo(a)pyrene- detoxification pathway Cancer Res. 64 2004 3617 3623 (Pubitemid 38657940)
30. Z. Zheng, J.L. Fang, and P. Lazarus Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues Drug Metab. Dispos 30 2002 397 403 (Pubitemid 34263824)
31. H. Glatt Sulfotransferases in the bioactivation of xenobiotics Chem. Biol. Interact 129 2000 141 170 (Pubitemid 32061058)
32. J. Beane, P. Sebastiani, G. Liu, J.S. Brody, M.E. Lenburg, and A. Spira Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression Genome Biol. 8 2007 R201
33. R. Chari, K.M. Lonergan, R.T. Ng, C. MacAulay, W.L. Lam, and S. Lam Effect of active smoking on the human bronchial epithelium transcriptome BMC Genomics 8 2007 297
34. W. Wilson 3rd, F. Pardo-Manuel de Villena, B.D. Lyn-Cook, P.K. Chatterjee, T.A. Bell, D.A. Detwiler, R.C. Gilmore, I.C. Valladeras, C.C. Wright, D.W. Threadgill, and D.J. Grant Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15 Genomics 84 2004 707 714 (Pubitemid 39310948)
35. H.J. Edenberg, R.E. Jerome, and M. Li Polymorphism of the human alcohol dehydrogenase 4 (ADH4) promoter affects gene expression Pharmacogenetics 9 1999 25 30 (Pubitemid 29176720)
36. T.O. Lankisch, A. Vogel, S. Eilermann, A. Fiebeler, B. Krone, A. Barut, M.P. Manns, and C.P. Strassburg Identification and characterization of a functional TATA box polymorphism of the UDP glucuronosyltransferase 1A7 gene Mol. Pharmacol. 67 2005 1732 1739 (Pubitemid 40594174)
37. H. Yamanaka, M. Nakajima, M. Katoh, Y. Hara, O. Tachibana, J. Yamashita, H.L. McLeod, and T. Yokoi A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A922) and its effects on the transcriptional activity Pharmacogenetics 14 2004 329 332 (Pubitemid 38638920)
38. C.A. Guy, B. Hoogendoorn, S.K. Smith, S. Coleman, M.C. O'Donovan, and P.R. Buckland Promoter polymorphisms in glutathione-S-transferase genes affect transcription Pharmacogenetics 14 2004 45 51 (Pubitemid 38183961)
39. Y. Ji, O.E. Salavaggione, L. Wang, A.A. Adjei, B. Eckloff, E.D. Wieben, and R.M. Weinshilboum Human phenylethanolamine N-methyltransferase pharmacogenomics: gene re-sequencing and functional genomics J. Neurochem. 95 2005 1766 1776 (Pubitemid 41804072)
40. A. Heils, A. Teufel, S. Petri, G. Stober, P. Riederer, D. Bengel, and K.P. Lesch Allelic variation of human serotonin transporter gene expression J. Neurochem. 66 1996 2621 2624 (Pubitemid 26159101)
41. S.W. Yee, J.E. Shima, S. Hesselson, L. Nguyen, S. De Val, R.J. Lafond, M. Kawamoto, S.J. Johns, D. Stryke, P.Y. Kwok, T.E. Ferrin, B.L. Black, D. Gurwitz, N. Ahituv, and K.M. Giacomini Identification and characterization of proximal promoter polymorphisms in the human concentrative nucleoside transporter 2 (SLC28A2) J. Pharmacol. Exp. Ther. 328 2009 699 707
42. J.A. Price, S.C. Fossey, M.M. Sale, C.S. Brewer, B.I. Freedman, J.P. Wuerth, and D.W. Bowden Analysis of the HNF4 alpha gene in Caucasian type II diabetic nephropathic patients Diabetologia 43 2000 364 372 (Pubitemid 30163480)
43. O. Hankinson Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor Arch. Biochem. Biophys. 433 2005 379 386 (Pubitemid 39592792)
44. M. Ingelman-Sundberg, S.C. Sim, A. Gomez, and C. Rodriguez-Antona Influence of cytochrome P450 p.lymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects Pharmacol. Ther. 116 2007 496 526 (Pubitemid 350116943)
45. E. Brambilla, and S. Lantuejoul Eur. Respir. Mon 44 2009 15 35
46. M.E. Garber, O.G. Troyanskaya, K. Schluens, S. Petersen, Z. Thaesler, M. Pacyna-Gengelbach, M. van de Rijn, G.D. Rosen, C.M. Perou, R.I. Whyte, R.B. Altman, P.O. Brown, D. Botstein, and I. Petersen Diversity of gene expression in adenocarcinoma of the lung Proc Natl Acad Sci U S A 98 2001 13784 13789 (Pubitemid 33115976)
47. A. Gazdar, W.A. Franklin, E. Brambilla, P. Hainaut, J. Yokota, and C.C. Harris Genetic and molecular alterations W.D. Travis, E. Brambilla, H.K. Mueller-Hermelink, C.C. Harris, Tumours of the Lung. Tumours of the Lung, Pleura, Thymus and Heart. World Health Organization Classification of Tumours. Pathology and Genetics 2004 IARC Press Lyon 21 33
48. E.P. Kopantzev, G.S. Monastyrskaya, T.V. Vinogradova, M.V. Zinovyeva, M.B. Kostina, O.B. Filyukova, A.G. Tonevitsky, G.T. Sukhikh, and E.D. Sverdlov Differences in gene expression levels between early and later stages of human lung development are opposite to those between normal lung tissue and non-small lung cell carcinoma Lung Cancer 62 2008 23 34
49. C. Toussaint, N. Albin, L. Massaad, D. Grunenwald, O. Parise Jr., J. Morizet, A. Gouyette, and G.G. Chabot Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues Cancer Res. 53 1993 4608 4612 (Pubitemid 23304387)
50. K.T. Kivisto, E.U. Griese, P. Fritz, A. Linder, J. Hakkola, H. Raunio, P. Beaune, and H.K. Kroemer Expression of cytochrome P 450 3A enzymes in human lung: a combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumours Naunyn Schmiedebergs Arch. Pharmacol. 353 1996 207 212
51. P. Martinez-Moreno, S. Nieto-Ceron, J. Torres-Lanzas, F. Ruiz-Espejo, I. Tovar-Zapata, P. Martinez-Hernandez, J.N. Rodriguez-Lopez, C.J. Vidal, and J. Cabezas-Herrera Cholinesterase activity of human lung tumours varies according to their histological classification Carcinogenesis 27 2006 429 436 (Pubitemid 43372872)
52. S. Ohtsuki, M. Kamoi, Y. Watanabe, H. Suzuki, S. Hori, and T. Terasaki Correlation of induction of ATP binding cassette transporter A5 (ABCA5) and ABCB1 mRNAs with differentiation state of human colon tumor Biol. Pharm. Bull. 30 2007 1144 1146 (Pubitemid 46883871)
53. S. Liu, A. Stromberg, H.H. Tai, and J.A. Moscow Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells Mol. Cancer Res. 2 2004 477 487 (Pubitemid 39121510)
54. S.M. Sy, N. Wong, T.W. Lee, G. Tse, T.S. Mok, B. Fan, E. Pang, P.J. Johnson, and A. Yim Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung Eur. J. Cancer 40 2004 1082 1094 (Pubitemid 38496267)
55. I.M. Adcock, P. Ford, K. Ito, and P.J. Barnes Epigenetics and airways disease Respir. Res. 7 2006 21
56. K. Kaira, N. Oriuchi, H. Imai, K. Shimizu, N. Yanagitani, N. Sunaga, T. Hisada, S. Tanaka, T. Ishizuka, Y. Kanai, H. Endou, T. Nakajima, and M. Mori Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer Br. J. Cancer 98 2008 742 748 (Pubitemid 351272621)
57. C. Wang, R. Yan, D. Luo, K. Watabe, D.F. Liao, and D. Cao Aldo-keto reductase family 1 member B10 p.omotes cell survival by regulating lipid synthesis and eliminating carbonyls J. Biol. Chem. 2009
58. S. Fukumoto, N. Yamauchi, and H. Moriguchi Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas Clin. Cancer Res. 11 2005 1776 1785 (Pubitemid 40471839)
59. M.L. Macheda, S. Rogers, and J.D. Best Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer J. Cell Physiol. 202 2005 654 662 (Pubitemid 40175840)
60. M.T. Kuo, H.H. Chen, I.S. Song, N. Savaraj, and T. Ishikawa The roles of copper transporters in cisplatin resistance Cancer Metastasis Rev. 26 2007 71 83 (Pubitemid 46452185)
61. T. Oguri, H. Achiwa, H. Muramatsu, H. Ozasa, S. Sato, S. Shimizu, H. Yamazaki, T. Eimoto, and R. Ueda The absence of human equilibrative nucleoside transporter 1 expression predicts nonresponse to gemcitabine-containing chemotherapy in non-small cell lung cancer Cancer Lett. 256 2007 112 119 (Pubitemid 47333332)
62. B. Monsarrat, E. Chatelut, I. Royer, P. Alvinerie, J. Dubois, A. Dezeuse, H. Roche, S. Cros, M. Wright, and P. Canal Modification of paclitaxel metabolism in a cancer patient by induction of cytochrome P450 3A4 Drug Metab. Dispos. 26 1998 229 233 (Pubitemid 28182398)
63. F.K. Engels, A.J. Ten Tije, S.D. Baker, C.K. Lee, W.J. Loos, A.G. Vulto, J. Verweij, and A. Sparreboom Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxel Clin. Pharmacol. Ther. 75 2004 448 454 (Pubitemid 38534565)
64. D. Dai, D.C. Zeldin, J.A. Blaisdell, B. Chanas, S.J. Coulter, B.I. Ghanayem, and J.A. Goldstein Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid Pharmacogenetics 11 2001 597 607 (Pubitemid 32953585)
65. M. Shou, M. Martinet, K.R. Korzekwa, K.W. Krausz, F.J. Gonzalez, and H.V. Gelboin Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives: enzyme specificity, interindividual distribution and metabolic contribution in human liver Pharmacogenetics 8 1998 391 401 (Pubitemid 28475303)
66. R. Rizzo, F. Spaggiari, M. Indelli, G. Lelli, O.R. Baricordi, P. Rimessi, and A. Ferlini Association of CYP1B1 with hypersensitivity induced by Taxane therapy in breast cancer patients Breast Cancer Res. Treat. 124 2010 593 598
67. D.J. Stewart Mechanisms of resistance to cisplatin and carboplatin Crit. Rev. Oncol. Hematol. 63 2007 12 31 (Pubitemid 46810280)
68. M.H. Mossink, A. van Zon, R.J. Scheper, P. Sonneveld, and E.A. Wiemer Vaults: a ribonucleoprotein particle involved in drug resistance? Oncogene 22 2003 7458 7467 (Pubitemid 37487169)